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Edited by Sandro SonninoAbstract Sialic acids are expressed as terminal sugars in many
glycoconjugates and play an important role during development
and regeneration, as they are involved as polysialic acid in a vari-
ety of cell–cell interactions mediated by the neural cell adhesion
molecule NCAM. The key enzyme for the biosynthesis of sialic
acid is the UDP-N-acetylglucosamine 2-epimerase/N-acetyl-
mannosamine-kinase (GNE). Mutations in the binding site of
the feedback inhibitor CMP-sialic acid of the GNE leads to sial-
uria, a disease in which patients produce sialic acid in gram scale.
Here, we report on the consequences after expression of a sialu-
ria-mutated GNE. Expression of the sialuria-mutated GNE
leads to a dramatic increase of both cellular sialic acid and poly-
sialic acid on NCAM. This could also be achieved by application
of the sialic acid precursor N-acetylmannosamine. Our data sug-
gest that biosynthesis of sialic acid regulates and limits the syn-
thesis of polysialic acid.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
Keywords: UDP-N-Acetylglucosamine 2-epimerase/
N-acetylmannosaminekinase; N-Acetylmannosamine1. Introduction
Sialic acid [1] is the most abundant terminal monosaccharide
on glycoconjugates of the eukaryotic cell surface. It is involved
in a variety of cellular functions, such as cell–cell interaction,
virus infection or the stability of glycoproteins [2–4]. One
prominent example of a highly sialylated glycoprotein is the
neural cell adhesion molecule NCAM [5]. It is known for its
expression of polysialic acid [6,7]. Polysialic acid is a unique
and highly regulated posttranslational modiﬁcation of
NCAM. The presence of polysialic acid aﬀects NCAM-depen-
dent cell adhesion and plays an important role during brain
development, neural regeneration and plastic processes includ-
ing learning and memory [8,9]. Polysialylated-NCAM is also
re-expressed on several neuroendocrine or lung tumors of high
malignancy and correlates with poor prognosis [10,11]. Two
closely related enzymes, the polysialyltransferases ST8SiaIV
[12,13] and ST8SiaII [14,15], catalyze the biosynthesis of poly-
sialic acid (Fig. 1). However, the impact of each enzyme in
NCAM polysialylation is not understood.*Corresponding author. Fax: +49 30 8445 1541.
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doi:10.1016/j.febslet.2005.08.013Sialic acids are synthesized in the cytosol from UDP-N-acet-
ylglucosamine by four consecutive reactions (Fig. 1). The ﬁrst
two steps in sialic acid biosynthesis are catalyzed by one
bi-functional enzyme, the UDP-N-acetylglucosamine 2-epimer-
ase/N-acetylmannosamine-kinase (GNE) [16,17]. Inactivation
of GNE is embryonic lethal, indicating the fundamental role
of sialic acid in vivo [18]. The clinical relevance of the GNE is
demonstrated by the detection of a binding defect of the feed-
back inhibitor CMP-sialic acid. This is leading to a sialic acid
storage disease termed sialuria. In sialuria, free sialic acid accu-
mulates in the cytoplasm resulting in severe mental retardation
of the surviving patients [19]. Recently, it has been demon-
strated that mutations in the GNE are also responsible for
the development of a hereditary inclusion body myopathy [20].
In this study, we report the overexpression of GNE contain-
ing a sialuria point mutation (GNE-sialuria) in PC12- and
CHO-cells transfected with either ST8SiaII or ST8SiaIV. The
total sialic acid concentration in GNE-sialuria-expressing cells
is dramatic increased compared to wild type-cells. In agree-
ment with this, application of the physiological precursor of
sialic acid, N-acetylmannosamine (ManNAc), also resulted in
increased cellular sialic acid. However, transfection of CHO-
cells with the feedback-regulated wild type GNE did not result
in increased sialic acid concentration. When analyzing PSA in
ST8SiaII or ST8SiaIV-expressing CHO-cells, we found a dra-
matic increase of polysialic acid after transfection with
GNE-sialuria or application of ManNAc, both leading to
increased sialic acid concentration. Transfection of CHO-cells
with wild type GNE did not result in increased sialic acid
concentration and subsequently did not increase the expression
of polysialic acid. These data suggest that polysialylation of
NCAM is exclusively regulated by the synthesis of sialic acid
at the level of the GNE and that therefore the cellular sialic
acid concentration limits both polysialyltransferases ST8SiaII
and ST8SiaIV.2. Materials and methods
2.1. Cell culture, antibodies and N-acetyl D-mannosamine
All cells transfected with or without polysialyltransferase ST8SiaII
or ST8SiaIV were cultivated in Falcon plastic ﬂasks or dishes in
alpha-MEM (CHO) or RPMI 1640 (PC12) supplemented with 10%
fetal calf serum (CHO) or 10% horse serum (PC12). Monoclonal
anti-PSA antibody 735 was used as IgG. Antibodies to actin were
purchased from Sigma and mouse immunoglobulins conjugated to
HRP were obtained from Dianova. N-Acetyl D-mannosamine was
purchased from Sigma.blished by Elsevier B.V. All rights reserved.
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Fig. 1. Biosynthesis of sialic acid and polysialylated NCAM ManNAc (1) is the precursor of sialic acid. All ManNAc is converted to sialic acid.
The key enzyme for the generation of ManNAc is GNE (2). GNE is feedback inhibited by activated (CMP-) sialic acid (red arrow). The activated
sialic acid will then be used by polysialyltransferases (ST8Sia II or ST8Sia IV) to generate polysialylated (PSA) NCAM within the Golgi (green
arrow).
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The PSA-negative CHO-mutant 2A10 was used to generate stable
transfected cell lines expressing either ST8SiaII or ST8SiaIV. The
full-length genes of hamster ST8SiaIV and murine ST8SiaII were
cloned in pcDNA3 (Invitrogen) and transfected with Lipofectamine
(Invitrogen) according to the manufactures protocol. Three days after
transfection, stable transfected cells were selected by adding 750 lg/ml
G418 (Calbiochem). Single cell clones were isolated by limiting dilu-
tion, propagated and checked for polysialic acid expression by immu-
nocytochemistry and Western blot analysis using the anti-PSA
antibody 735.
2.3. Generation of transient transfected CHO-cells
CHO-mutant 2A10 cells expressing either ST8Sia II or ST8Sia IV
were transient transfected with Lipofectamine (Invitrogen) according
to the instruction of the manufacturer. After 48 h, cells were selected
by adding 500 ng/ml zeocin (Invitrogen). Cells were harvested after
six days prior to further investigation.
2.4. Preparation of cell extracts and fractions
Nuclear and cytosolic extracts of CHO-cells were prepared using the
NucBustere protein extraction kit (Novagen) according to the
instruction of the manufacturer. Cell pellets were solubilized at 4 C
for 1 h in buﬀer containing 150 mM NaCl, 10 mM Tris, 1 mM CaCl2,
1 mMMgCl2, 1% Triton and a protease inhibitor cocktail (P 8340, Sig-
ma) at pH 7.4. Solubilisates were centrifuged at 30000 · g for 15 min
and supernatants were collected and further analyzed by Western blot
analysis.
2.5. Generation of GNE-sialuria mutation
The point mutation R263L (sialuria mutation) of the GNE was
introduced using the QuikChangeTM site-directed mutagenesis kit
(Stratagene) and cloned into the pFastBacHTA vector. This vector
was a gift of Dr. S. Hinderlich (Berlin). Mutated GNE was then
cloned into pcDNA3.1 () zeocin vector (Invitrogen) using XhoI
and KpnI restriction sites. Sequencing proofed the sequence of this
construct.
2.6. Endoneuraminidase NE treatment of detergent cell extracts
Detergent cell extracts (5 mg/ml) were incubated with a 1:100 dilu-
tion of recombinant endoNE and incubated at 37 C for 1 h.2.7. Immunoblotting
Samples were separated on SDS–polyacrylamide gels (BioRad) and
transferred to nitrocellulose ﬁlters. The blots were blocked with 4% fat-
free dry milk powder in PBS, incubated with the respective primary
antibodies or with streptavidin conjugated with peroxidase, washed
with PBS and incubated with the appropriate secondary antibodies.
After washing, proteins were detected by enhanced chemiluminescence
(Amersham Buchler) according to the manufacturers instructions, and
visualized by exposing the blots to a Fuji imager system (LAS) for time
periods between 10 and 120 s.2.8. Sialic acid quantiﬁcation
Free sialic acid was quantiﬁed by the periodate/resorcinol method.
In brief, lysates from 20 · 106 cells were oxidized in 250 ll with 5 ll
of 0.4 M periodic acid at 37 C for 90 min, followed by 15 min boiling
in 500 ll of 6% resorcinol/2.5 mM CuSO4/44% HCl. After cooling for
a few minutes, 500 ll tert-butyl alcohol were added, the samples were
vortexed and centrifuged for 5 min to precipitate cell debris. Immedi-
ately after spinning, the supernatants were poured into OD cuvettes
and read at 630 nm. Sialic acid concentrations were calculated by com-
parison with a standard curve.3. Results
3.1. Sialic acid concentration in the cytosol and in the nucleus
Since no data were available on the concentration of intra-
cellular sialic acid, we quantiﬁed sialic acid in cytosolic frac-
tions and nuclei preparations. We analyzed three diﬀerent
cell lines (Jurkat, PC12 and CHO). To our surprise we mea-
sured in all cell lines very high sialic acid concentration in
the nucleus. The concentration of free sialic acid in the cytosol
of CHO-cells was 3.5 nmol/mg compared to 4.5 nmol/mg in
the nucleus (Fig. 2). We then incubated isolated nuclei with
PBS for 15 and 30 min at room temperature to allow diﬀusion
of sialic acid from the nucleus. When quantifying the sialic
acids of these nuclei, we found the same concentration
(4.5 nmol/mg) of sialic acid compared to untreated nuclei. This
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Fig. 2. Concentration of sialic acid in cytosolic and nuclear extracts
Cells were fractionated to obtain cytosolic and nuclear fractions. Sialic
acid concentration was measured using the periodate/resorcinol
method. Bars represent mean values ± S.D. of three independent
experiments carried out in duplicate.
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and cannot easily diﬀuse through the nuclear pores.
This is to our knowledge the ﬁrst report on free sialic acid in
the nucleus. These results support the data of Krause et al.
[21], who very recently demonstrated GNE localization not
only in the cytosol, but also within the nucleus.
3.2. Increasing the concentration of cellular sialic acid
We then tried to increase the cellular concentration of total
sialic acid by the following strategies: First, we transfected
CHO-cells (CHO-2A10-ST8SiaII) with the wild type GNE
(GNE-wt). This did not result in increased concentration of
sialic acid (Fig. 3A). However, after transfection with a mu-
tated GNE (GNE-sialuria), which carries a sialuria mutation
and subsequently produces sialic acid without feedback inhibi-Fig. 3. Concentration of total cellular sialic acid. (A) CHO-2A10-ST8SiaII-c
(GNE-sialuria) or cultured in the presence of 10 mM ManNAc for 72 h. For
acid concentration was measured using the periodate/resorcinol method. Bars
out in duplicate. (B) CHO-cells were cultured in the presence of 10 mM Ma
using the periodate/resorcinol method. Bars represent mean values ± S.D. of
were cultured in the presence of 1, 5, 10, or 50 mMManNAc for 72 h. Sialic a
Bars represent mean values of a representative experiments carried out in dution, we found a twofold increase of total sialic acid (Fig. 3A).
Second, we added the sialic acid precursor N-acetylmannos-
amine (ManNAc) for 72 h to the cultures. This procedure led
also to a more than twofold increase of sialic acid (Fig. 3A).
In a second set of experiments we analyzed the concentration-
and time-dependency of ManNAc-application to total cellular
sialic acids concentration of CHO-cells. First, we analyzed the
time-dependency. Fig. 3B shows the result of 10 mM Man-
NAc-application to CHO-cells for 3, 5, 12, 24, or 48 h. Appli-
cation of 10 mM ManNAc led to a continuous increase in
sialic acid concentration. Longer applications (72 h) with
10 mM ManNAc resulted only in a minor increase of sialic
acid compared to 48 h as shown in Fig. 3A. We then analyzed
the concentration-dependency. Fig. 3C shows the result of 1, 5,
10 or 50 mM ManNAc-application to CHO-cells for 72 h.
Application of ManNAc led to a continuous increase in sialic
acid concentration. Application of 10 mM ManNAc led to the
same concentration of sialic acid as measured in the experi-
ments of Fig. 3A or B. However, when CHO-cells were grown
in medium containing 50 mM ManNAc (a very high concen-
tration, which alters the osmolarity within the culture medium
dramatically) we could measure very high concentration of sia-
lic acid. Higher concentration than 50 mM are toxic.
3.3. Increasing intracellular levels of sialic acid results in an
increase in polysialylation of NCAM
CHO-2A10-cells do not express any polysialtransferase and
subsequently do not express polysialylated NCAM. After
transfection with either ST8SiaII or ST8SiaIV both cell lines
(CHO-2A10-ST8SiaII- and CHO-2A10-ST8SiaIV) express
polysialylated NCAM [22].
We then transfected both cell lines with GNE. Transfection
of CHO-2A10-ST8SiaII- or CHO-2A10-ST8SiaIV-cells did
not result in increased expression of polysialylated NCAM
(Fig. 4A). This is due to the feedback inhibition of GNE
leading to constant levels of intracellular sialic acid levels.
However, after transfection of CHO-2A10-ST8SiaII- or
CHO-2A10-ST8SiaIV-cells with a mutated GNE, whichells were transfected with wild type GNE (GNE-wt) or mutated GNE
control, untreated cells were used (no transfection/no addition). Sialic
represent mean values ± S.D. of three independent experiments carried
nNAc for 3, 5, 12, 24 or 48 h. Sialic acid concentration was measured
three independent experiments carried out in duplicate. (C) CHO-cells
cid concentration was measured using the periodate/resorcinol method.
plicate.
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acid without feedback inhibition, we found increased expres-
sion of polysialylated NCAM (Fig. 4B). Similar results were
obtained after growing cells in the presence of ManNAc, which
is converted to free sialic acid and CMP-sialic acid (Fig. 4C).
The increased expression of polysialylated NCAM is
concentration dependent and reaches its maximum at 50 mM
ManNAc (data not shown). Interestingly, when we quantiﬁed
the concentration of total cellular bound sialic acid in CHO-
2A10-cells before and after transfection with GNE-sialuria of
feeding ManNAc, we measured equal concentration of bound
sialic acid (data not shown). The polysialic acid-speciﬁc en-
zyme endoneuraminidase NE was used to proof the speciﬁcity
of the Western blot analysis (Fig. 4D). The experiment shown
in Fig. 4 was repeated and the expression of polysialic acid was
quantiﬁed and summarized in Fig. 5.4. Discussion
The key enzyme for the biosynthesis of sialic acid is GNE. A
point mutation in the GNE leads to a loss of feedback inhibi-
tion and to the massive production of sialic acid in vitro andControl GNE GNE-sialuria ManNAc
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Fig. 5. Quantiﬁcation of polysialylation of NCAM CHO-2A10-ST8SiaII-
(GNE) or mutated GNE (GNE-sialuria) or cultured in the presence of 10m
polysialic acid speciﬁc antibody 735. Band intensities were quantiﬁed using IP
100%.
Fig. 4. Analysis of polysialylation of NCAMCHO-2A10-ST8SiaII- or CHO-2
or mutated GNE (GNE-sialuria, B) or cultured in the presence of 10 mM Ma
speciﬁc antibody 735. For control lysates were also analyzed after treatment win vivo. We took advantage of this GNE-defect and expressed
the GNE-R263L mutation (=GNE-sialuria) in CHO-cells.
Expression of GNE-sialuria led to an increase of total sialic
acid by more than twofold in CHO-cells. When analyzing
transfected 2A10-CHO-ST8SiaII- or -ST8SiaIV-cells by means
of Western blot, we found a dramatic increase of polysialy-
lated NCAM.
Although polysialyltransferases, which are responsible for
the polysialylation of NCAM, have been studied since many
years, little is known how the activity of these two speciﬁc
enzymes is regulated. It has been suggested that calcium
and/or phosphorylation of polysialyltransferases by the
protein kinase C is involved [23]. Kinetic data of poly-
sialyltransferases are unfortunately not available, whereas it
has been shown that the km-value for some sialyltransferases
is below 1 mM [24]. In our study, we analyzed the role of
concentration of cellular sialic acid on the expression of
polysialylated NCAM. Both, overexpression of sialic acid
by the mutated key enzyme of sialic acid biosynthesis or
application of ManNAc led to an increase of total cellular
sialic acid and of polysialic acid on NCAM. This is in agree-
ment with earlier observations that application of ManNAc
increases the pool of CMP–sialic acid [25]. However, the con-Control GNE GNE-sialuria ManNAc
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or CHO-2A10-ST8SiaIV-cells were transfected with wild type GNE
M ManNAc for 72 h (ManNAc). Cell lysates were analyzed using the
-lab software. Expression of polysialic acid of untreated cells was set to
A10-ST8SiaIV-cells were transfected with wild type GNE (GNE-wt, A)
nNAc for 72 h (C). Cell lysates were analyzed using the polysialic acid
ith endoneuramindase NE (NE, D), which removes all polysialic acid.
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(data not shown), what might be explained by missing or
limited acceptor sites for sialic acids on glycoproteins. Most
sialic acid is bound to galactose on conventional sialylated
glycoproteins. These glycoproteins are fully sialylated and
no free galactose is available for additional sialylation. In
contrast, NCAM is theoretically the only unlimited acceptor
for sialic acids, since on polysialylated NCAM sialic acids
are added to sialic acids. However, NCAM is not a major
protein of CHO-cells and therefore the additional sialic acids
on polysialylated NCAM do not contribute to the amount of
total cellular sialic acids. These data suggest that the in-
creased level of sialic acid due to the expression of GNE-
sialuria has no eﬀect on the total cellular sialylation of
glycoconjugates.
These results provide strong evidence that the concentra-
tion of sialic acid is regulating the content of polysialic acid
on NCAM. This implies that limiting concentration of sialic
acid is one of several factors that may regulate the expression
of polysialic acid on NCAM. By simply increasing the sialic
acid concentration using GNE-sialuria-transfected cells or
the addition of ManNAc (because ManNAc is the product
of the GNE reaction, the feedback mechanism fails; see
Fig. 1) it is possible to increase the amount of polysialic acids
on NCAM. Since polysialylation is associated with learning
and memory, it might be an interesting aspect to analyze
the expression of polysialic acid in patients suﬀering Sialuria,
since in some cases a mental retardation of these patients has
been observed.Acknowledgements: The authors thank Dr. S. Hinderlich for providing
GNE-sialuria cDNA and acknowledge Ilona Danßmann for technical
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